Investigators concluded, “To our knowledge, this is the first longitudinal cohort study … to report an absence of a relationship between cannabis use and risk of AF.”
Topic: Health/Safety
Researchers “did not find evidence of increases in health service use or incident cases of psychotic disorders over the short-term (17 month) period following cannabis legalization.”
Eighty-eight percent of those surveyed reported that cannabis “reduced their neuropathic pain intensity by more than 30 percent.”
“This is the first population-level prospective study to contribute evidence that medical cannabis is safe for a wide variety of symptoms,” investigators concluded.
Patients who used cannabis flower were most likely to show clinical improvements.
Patients taking oral THC also experienced reduced pain, fatigue, and depressive symptoms.
“These results suggest that cannabis-based medicinal products may play a role in alleviating symptoms and co-morbid anxiety and sleep disruption associated with ADHD.”
Young adults in California were less likely to report using either alcohol or cigarettes following cannabis legalization.